HYPRMICRO

Hyperfine, Inc.

HealthcareMedical - Devices
$1.27
$0.00(-2.31%)
52W$0.76
$2.22
Updated Jul 7, 02:00 AM
RSI41
RS Rating45/99
Beta2.69
Volatility95%
F-Score3/9
Mkt Cap$107M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Hyperfine, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 45), showing significant lag compared to the market leaders. Earnings growth of 25% provides fundamental context to the price action. Investors should exercise caution due to high volatility (95% annualized), which requires wider risk management.

Relative Strength
45
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
2.69
vs S&P 500
HIGH BETA
52W Position
35%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.50
50 SMA > 100 SMA$1.33
100 SMA > 150 SMA$1.25
150 SMA > 200 SMA$1.27

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.42-10.63%BELOW
50 SMA$1.50-15.50%BELOW
100 SMA$1.33-4.65%BELOW
150 SMA$1.25+1.93%ABOVE
200 SMA$1.27-0.18%BELOW

Price Performance

1D-2.3%
1W-11.8%
1M-9.9%
3M+11.4%
6M+24.5%
YTD+31.1%
1Y+66.0%
3Y-16.5%
52-Week Trading Range35% from low
$1.27
52W Low$0.76
52W High$2.22

Technical Indicators

RSI (14)NEUTRAL
41.2
305070
Setup ScoreCOOL
1/10
Base depth: 64.2%

Risk Profile

Beta
2.69
52W Vol
95%
ATR
$0.13
Max DD (1Y)
-59%

Volume Analysis

Today
1.03M
50D Avg
846.7K
Vol Ratio
1.21x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+14%
$-0.12
Q3'25
$-0.14
Q4'25+55%
$-0.06
Q1'26+25%
$-0.09
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+115.18%
3 Years:+25.79%
TTM:+30.66%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+23.56%

Stock Price CAGR

10 Years:-18.65%
5 Years:-33.65%
3 Years:-16.55%
1 Year:+66.01%

Return on Equity

10Y Avg:-56.4%
5Y Avg:-56.2%
3Y Avg:-60.9%
Last Year:-101.3%

Key Metrics

Market Cap$107M
Gross Margin49.8%
Net Margin-2.6%
Piotroski F-Score3/9

Frequently Asked Questions

Is HYPR in an uptrend right now?

HYPR has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is HYPR overbought or oversold?

HYPR's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.

Is HYPR outperforming the market?

HYPR has a Relative Strength (RS) Rating of 45 out of 99. HYPR is currently lagging the broader market.

Where is HYPR in its 52-week range?

HYPR is trading at $1.27, which is 57% of its 52-week high ($2.22) and 35% above its 52-week low ($0.76).

How volatile is HYPR?

HYPR has a Beta of 2.69 and 52-week volatility of 95%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.